Predictive Oncology Past Earnings Performance

Past criteria checks 0/6

Predictive Oncology's earnings have been declining at an average annual rate of -22.4%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 5% per year.

Key information

-22.4%

Earnings growth rate

52.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate5.0%
Return on equity-139.0%
Net Margin-1,802.4%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Predictive Oncology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:S1K Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 231-26160
31 Dec 222-26160
30 Sep 222-26160
30 Jun 221-27150
31 Mar 221-19140
31 Dec 211-20140
30 Sep 211-23130
30 Jun 211-25130
31 Mar 211-26140
31 Dec 201-26130
30 Sep 201-29130
30 Jun 201-26140
31 Mar 201-21150
31 Dec 191-20140
30 Sep 191-9150
30 Jun 191-8130
31 Mar 191-1290
31 Dec 181-1090
30 Sep 181-870
30 Jun 181-660
31 Mar 181-670
31 Dec 171-670
30 Sep 171-660
30 Jun 171-660
31 Mar 171-650
31 Dec 160-760
30 Sep 161-870
30 Jun 160-870
31 Mar 161-770
31 Dec 151-550
30 Sep 151-550
30 Jun 151-550
31 Mar 151-560
31 Dec 141-770
30 Sep 141-770
30 Jun 141-990
31 Mar 140-990
31 Dec 130-990
30 Sep 130-980
30 Jun 130-880
31 Mar 130-990
31 Dec 120-770
30 Sep 120-980

Quality Earnings: S1K is currently unprofitable.

Growing Profit Margin: S1K is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: S1K is unprofitable, and losses have increased over the past 5 years at a rate of 22.4% per year.

Accelerating Growth: Unable to compare S1K's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: S1K is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: S1K has a negative Return on Equity (-138.99%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies